Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Alioth Biotech logo — Your Reliable Partner in Pharma Filtration Processing

Alioth Biotech

Your Reliable Partner in Pharma Filtration Processing

Founded 2021 China China 22 employees Series A Total: $190.00M Biopharma, Biotechnology +2

General Information

Company Name Alioth Biotech
Founded Year 2021
Location China China
Employees 22
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series A
Business Model B2B, D2C
Revenue Model Product Sales, Service Fee, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Alioth Biotech. To contact Alioth Biotech, visit aliothbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alioth Biotech compare?

A PDF of Alioth Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alioth Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alioth Biotech

Alioth Biotech, founded in 2021, is a fast-growing, technology-driven company dedicated to advancing pharmaceutical filtration and membrane separation solutions. Headquartered in China, the company leverages R&D expertise from teams based in Boston and Shanghai to develop innovative filtration membranes that enhance drug manufacturing processes.

Maintaining high standards, Alioth Biotech operates under ISO9001 and adheres to GMP guidelines, managing end-to-end manufacturing across expansive facilities. With a CNAS-accredited validation center and development labs, the company ensures the reliability and compliance of its solutions.

Recently, Alioth Biotech secured a significant CNY100.00M Series A investment on 10 October 2023, backed by prominent investors such as Legend Capital, Matrix Partners China, AstraZeneca CICC Medical Industry Fund, and Yi Shuishuishan. The influx of capital is set to propel their mission of becoming a "Reliable Partner in Pharma Filtration Processing" further.

Business keywords: Pharmaceutical Filtration, Membrane Separation, Filtration Membranes, Biopharmaceutical Processing, Sterile Filtration, Depth Filtration, Virus Removal Filtration, Ultrafiltration, R&D in Filtration Technology, GMP Compliance, ISO9001 Certification, Supply Chain Security, Process Development, Innovative Separation Solutions

Services & Products

Filtration Technology Development
Process Development Service
Validation Service
Manufacturing of Filtration Products

Target Customers

Pharmaceutical Companies Biopharmaceutical Manufacturers Drug Development Firms

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A CNY100.00M 4
Legend Capital Matrix Partners China
Legend Capital, Matrix Partners China +2
10 Oct 2023
Series A CNY90.00M 2
Legend Capital Matrix Partners China
Legend Capital, Matrix Partners China
13 Oct 2022

Alioth Biotech Alternatives & Competitors

View All Alternatives
Alioth Biotech vs
Filtravate
Filtravate United States

Filter the Future™

Seed
2 employees
Biotechnology, Pharmaceutical
Alioth Biotech vs
H2 PHARMA FRANCE
H2 PHARMA FRANCE France

Spécialiste Français de la fabrication des produits "liquides non-stériles"​.

Private Equity
57 employees
Biotechnology, Manufacturing
Alioth Biotech vs
Flamma
Flamma Italy

Family owned & run. Advancing amino acids & small molecules since 1950. See why FLAMMA is The Thinki...

452 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About Alioth Biotech

Your Reliable Partner in Pharma Filtration Processing
Alioth Biotech was founded in 2021.
Alioth Biotech is headquartered in China.
Alioth Biotech operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Pharmaceutical Filtration, Membrane Separation, Filtration Membranes and Biopharmaceutical Processing. Its customers include Pharmaceutical Companies, Biopharmaceutical Manufacturers and Drug Development Firms.
Alioth Biotech has a B2B and D2C business model. Its revenue comes from Product Sales, Service Fee and Consulting Fee.
Alioth Biotech has approximately 22 employees.
Alioth Biotech has completed 2 funding rounds, raising a total of $190.00M. The latest funding stage is Series A.
Alioth Biotech offers: Filtration Technology Development, Process Development Service, Validation Service, Manufacturing of Filtration Products.
Top alternatives and competitors to Alioth Biotech include Filtravate, H2 PHARMA FRANCE, Flamma, Batterjee Pharma, Vernalis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alioth Biotech and Filtravate are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alioth Biotech, https://bouncewatch.com/company/alioth-biotech, updated 30 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout